SABCS -POSTER´S SOBRE NOVAS DROGAS , AXIELCTOMIA , SIND LI FRAUMENI


 https://sabcs.onlineeventpro.freeman.com/posters/25581599/A-prospective-randomized-multicenter-double-blinded-placebo-controlled-phase-III-trial-of-the-HER2neupeptide-GP2--GM-CSF-versus-bacteriostatic-salineWFI-placebo-as-adjuvant-therapy-after-any-trastuzumab-based-therapy-in-HER2-positive-women-with-operable-breast-cancer


https://sabcs.onlineeventpro.freeman.com/posters/25581541/Tailored-axillary-surgery-with-or-without-axillary-lymph-node-dissection-followed-by-radiotherapy-in-patients-with-clinically-node-positive-breast-cancer-SAKK-2316--IBCSG-57-18--ABCSG-53--GBG-101---TAXIS-a-multicenter-randomized-phase-III-trial


https://sabcs.onlineeventpro.freeman.com/single-file-viewer/25582199




Comentários

Postar um comentário

Postagens mais visitadas deste blog

Imagem
 https://sabcs.onlineeventpro.freeman.com/posters/25581279/Efficacy-and-tolerability-of-neoadjuvant-Pertuzumab-Trastuzumab-and-weekly-Paclitaxel-in-Locally-advanced-Her-2-positive-Breast-cancer https://sabcs.onlineeventpro.freeman.com/posters/25582333/Phase-II-pilot-study-of-trastuzumab-biosimilar-herzuma-plus-gedatolisib-in-patients-with-HER-2-positive-metastatic-breast-cancer-who-progressed-after-2-or-more-HER-2-directed https://sabcs.onlineeventpro.freeman.com/posters/25581672/HER2CLIMB-02-A-randomized-double-blind-phase-3-study-of-tucatinib-or-placebo-with-T-DM1-for-unresectable-locally-advanced-or-metastatic-HER2-breast-cancer          
Leia mais